Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.

https://www.nih.gov/news-events/news-releases/combination-immunotherapy-shrank-variety-metastatic-gastrointestinal-cancers